The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes by number of induction cycles with CPX-351 vs 7+3 chemotherapy in older adults with newly diagnosed, high-risk/secondary acute myeloid leukemia (sAML).
 
Tara L. Lin
Honoraria - Jazz Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celator (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Imago Pharma (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Mateon Therapeutics (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Bruno C. Medeiros
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma; Celator; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Astellas Pharma; Celgene; MEI Pharma; Merck/Schering Plough; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Celator; Celgene; Jazz Pharmaceuticals; Novartis
 
Geoffrey L. Uy
Consulting or Advisory Role - Curis; Glycomimetics; Jazz Pharmaceuticals; Novartis; Novo Nordisk; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Laura Fugal Newell
No Relationships to Disclose
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals; Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Robert K. Stuart
Honoraria - Sunesis Pharmaceuticals
Consulting or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Agios (Inst); Astellas Pharma (Inst); Bayer (Inst); Celator/Jazz (Inst); Incyte (Inst)
Travel, Accommodations, Expenses - Sunesis Pharmaceuticals
 
Stephen Anthony Strickland
Consulting or Advisory Role - Alexion Pharmaceuticals; Astellas Pharma; Baxalta; Boehringer Ingelheim; CTI BioPharma Corp; Daiichi Sankyo; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Celator/Jazz (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst); Sunesis Pharmaceuticals (Inst)
 
Donna Hogge
Consulting or Advisory Role - Novartis; Roche
 
Scott R. Solomon
No Relationships to Disclose
 
Richard M. Stone
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bristol-Myers Squibb; Celator; Celgene; Fujifilm; Juno Therapeutics; Karyopharm Therapeutics; Merck; Novartis; Ono Pharmaceutical; Roche/Genentech; Theradex
Research Funding - Agios (Inst); Celator (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Dale L. Bixby
No Relationships to Disclose
 
Jonathan E. Kolitz
Stock and Other Ownership Interests - Celgene/Jazz
Honoraria - Gilead Sciences; Magellan Health
Consulting or Advisory Role - Gilead Sciences; Magellan Health; Novartis; Pharmacyclics; Seagen
Research Funding - Boehringer Ingelheim (Inst); Cantex Pharmaceuticals (Inst); ERYTECH Pharma (Inst); Millennium (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Seagen
 
Gary J. Schiller
Research Funding - Celator/Jazz (Inst)
 
Matthew Joseph Wieduwilt
Stock and Other Ownership Interests - Reata Pharmaceuticals
Research Funding - ADC Therapeutics (Inst); Amgen (Inst); Cantex (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Shire (Inst); Sigma-Tau (Inst)
 
Daniel H. Ryan
Stock and Other Ownership Interests - AbbVie
Patents, Royalties, Other Intellectual Property - University of Rochester
 
Robert J Ryan
Employment - Celator/Jazz
Stock and Other Ownership Interests - Celator/Jazz
 
Michael Chiarella
Employment - Celator; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
 
Arthur Chin Louie
Employment - Celator/Jazz
Stock and Other Ownership Interests - Celator/Jazz
 
Jeffrey E. Lancet
Consulting or Advisory Role - Astellas Pharma; Bio-Path Holdings, Inc; Biosight; Celgene; ERYTECH Pharma; Janssen; Jazz Pharmaceuticals
Research Funding - Pfizer (Inst)
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Novartis; Pfizer; Takeda
Research Funding - Ambit BioSciences (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst)